TABLE 1.

List of vaccines under phase trials for severe acute respiratory syndrome‐coronavirus‐2 infection ¹⁰² , ¹⁰³ , ¹⁰⁴ , ¹⁰⁵

Vaccine name	Technology	Industries/Institutes	Clinical trials
mRNA‐1273	RNA vaccine	Moderna, NIAID, Lonza	Phase III
CoronaVac	Inactivated virus	Sinovac, Instituto Butantan	Phase III
Bacillus Calmette‐Guerin (BCG)	Live‐attenuated vaccine	University of Melbourne and Murdoch Children's Research Institute, Radboud University Medical Center, Faustman Lab at Massachusetts General Hospital	Phase II/III
AZD1222	Replication‐deficient simian viral vector	The University of Oxford, Astrazeneca	Phase II/III
Ad5‐nCoV	Replication‐defecient adenovirus type 5	Cansino biological Inc.,	Phase II
RBD‐Dimer	Adjuvant recombinant vaccine	Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences	Phase II
Inactivated vaccine	Inactivated virus	Institute of Medical Biology, Chinese Academy of Medical Sciences	Phase I/II
BNT162	RNA vaccine	BioNTech, Fosun Pharma, Pfizer	Phase I/II
T‐COVIDTM	Replication‐deficient adenovirus 5	Altimmune	Phase I/II
GX‐19	DNA vaccine	Genexine	Phase I/II
BBIBP‐CorV	Inactivated virus	Beijing Institute of Biological Products, Sinopharm	Phase I/II
Inactivated vaccine	Inactivated virus	Wuhan Institute of Biological Products, Sinopharm	Phase I/II
INO‐4800	DNA vaccine	Inovio Pharmaceuticals, Inc.	Phase I/II
NVX‐CoV2373	Protein subunit	Novavax, Emergent BioSolutions, Praha Vaccines, Serum Institute of India, AGC Biologics	Phase I/II
BBV152 (Covaxin)	Inactivated virus	ICMR‐National institute of Virology, Pune, Bharat Biotech	Phase I/II
ZyCoV‐D	DNA Vaccine	Zydus Cadila Healthcare	Phase I/II
CVnCoV	mRNA vaccine	CureVac	Phase I
LNP‐CoVsaRNA	RNA vaccine	Imperial College London, VacEquity Global Health	Phase I
SCB‐2019	Protein subunit	Clover Biopharmaceuticals Inc., GSK, Dynavax	Phase I
bacTRL‐S	DNA Vaccine	Symvivo	Phase I
aAPC	Modified Lentiviral vector	Shenzhen Geno‐Immune Medical Institute	Phase I
LV‐SMENP‐DC	Modified Lentiviral vector	Shenzhen Geno‐Immune Medical Institute	Phase I
V‐SARS	Inactivated virus	Immunitor Inc.	Phase I
AV‐COVID‐19	Patient‐specific dendritic cell vaccine	Aivita Biomedical Inc.	Phase I
COVAX‐19	Protein subunit	Vaccine Pty, Flinders University, Oracle	Phase I
Molecular Clamp Vaccine	Protein subunit	University of Queensland CSL	Phase I
AG0301‐COVID19	DNA Vaccine	Osaka University, AnGes; Takara Bio	Phase I
ARCoV	mRNA Vaccine	PLA Academy of Military Sciences; Walvax Biotechnology	Phase I
Gam‐COVID‐Vac	Non‐replicating viral vector	Gamaleya Research Institute	Phase I
Plant‐derived VLP vaccine	Adjuvant recombinant vaccine	Medicago Inc., Universite Laval, GSK, Dynavax	Phase I